Quidel
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Quidel's revenues will grow 7.7% and EPS will come to zero.
The average estimate for revenue is $33.2 million. On the bottom line, the average EPS estimate is $0.00.
Revenue details
Last quarter, Quidel booked revenue of $62.0 million. GAAP reported sales were 61% higher than the prior-year quarter's $38.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.49. GAAP EPS of $0.36 for Q1 were much higher than the prior-year quarter's $0.00 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 69.3%, 830 basis points better than the prior-year quarter. Operating margin was 28.0%, much better than the prior-year quarter. Net margin was 20.2%, much better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $183.7 million. The average EPS estimate is $0.74.
Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 166 members out of 174 rating the stock outperform, and eight members rating it underperform. Among 46 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 45 give Quidel a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Quidel is outperform, with an average price target of $25.14.
Is Quidel the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Quidel to My Watchlist.
